Frederick Munschauer: Using Real World Evidence to Weigh Efficacy of Treatment

Video

While it may not be possible to compare the efficacy of treatments for multiple sclerosis in clinical trials work is being done to look at the various options through results in actual practice.

While it may not be possible to compare the efficacy of treatments for multiple sclerosis in clinical trials work is being done to look at the various options through results in actual practice.

Presenting data at the annual meeting of the Consortium of Multiple Sclerosis Centers Frederick Munschauer, MD, from EMD Serono discussed this new technique for measuring results which he said could be the future of the field. By being able to study thousands of similar patients he said it is possible to see how the drugs compare in their every day lives as opposed to a limited timeframe during the trials with a limited patient population.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Veraprapas Kittipibul, MD | Credit: X.com
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.